CIK 0001555280 · Pharmaceutical Preparations (SIC 2834) · NYSE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 9.5 B | 8.1 B | ||
| Net income (USD) | 1.6 B | 1.5 B | ||
| Diluted EPS (USD/shares) | 6.02 | 4.49 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-13 | 4 | FORM 4 | 2026-10-09 |
| 2026-10-13 | 4 | FORM 4 | 2026-10-09 |
| 2026-10-13 | 4 | FORM 4 | 2026-10-09 |
| 2026-10-13 | 4 | FORM 4 | 2026-10-09 |
| 2026-10-13 | 4 | FORM 4 | 2026-10-09 |
| 2026-10-13 | 4 | FORM 4 | 2026-10-09 |
| 2026-10-13 | 4 | FORM 4 | 2026-10-09 |
| 2026-10-13 | 4 | FORM 4 | 2026-10-09 |
| 2026-10-13 | 8-K | 8-K items 5.02,7.01,9.01 | 2026-10-08 |
| 2026-10-08 | 8-K | 8-K items 7.01,9.01 | 2026-10-08 |
| 2026-10-02 | 4 | FORM 4 | 2026-09-30 |
| 2026-09-18 | 4 | FORM 4 | 2026-09-17 |
| 2026-09-02 | 4 | FORM 4 | 2026-08-31 |
| 2026-08-24 | 3 | FORM 3 | 2026-08-17 |
| 2026-08-11 | 4 | FORM 4 | 2026-08-07 |
| 2026-08-06 | 8-K | 8-K items 5.02,9.01 | 2026-08-06 |
| 2026-08-06 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-06 | 8-K | 8-K items 2.02,9.01 | 2026-08-06 |
| 2026-07-30 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-14 | 4 | FORM 4 | 2026-07-10 |
| 2026-07-14 | 4 | FORM 4 | 2026-07-10 |
| 2026-07-14 | 4 | FORM 4 | 2026-07-10 |
| 2026-07-14 | 4 | FORM 4 | 2026-07-10 |
| 2026-07-14 | 4 | FORM 4 | 2026-07-10 |
| 2026-07-14 | 4 | FORM 4 | 2026-07-10 |
Forms on file (last 1,000): 4 773, 8-K 84, 144 30, 10-Q 20, 3 18, DEFA14A 9, SC 13G/A 8, 11-K 7. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ZTS (0.002 USD), /gw/filings/filings?ticker=ZTS&form=8-K, /gw/filings/facts?ticker=ZTS&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange